CRL - AbCellera Biologics: The Dilemma Of A Promising Pipeline Alongside Cash Burn
2025-06-13 13:45:12 ET
Investment Thesis
I grant AbCellera Biologics Inc. ( ABCL ) a Hold rating. In my opinion, the critical aspect of the company is whether it will have sufficient financial resources until at least one of its agreements with other firms, or its drug development program, yields results, assuming that these agreements or programs are successful....
AbCellera Biologics: The Dilemma Of A Promising Pipeline Alongside Cash Burn